Detailed Agenda 2017

Please click on arrow (left of each item) to display activities for the day

  • + -

    Thursday, November 16, 2017

    8:00 AM- 10:30 AM

    CNS Summit 2017 Leadership Council
    and Program Committee Meeting

    -- BY INVITATION ONLY --

    10:30 AM- 12:00 PM

    Clinical Trials of the Future:
    Domain Core Team Meetings
    -- BY INVITATION ONLY --

    12:00 PM- 1:00 PM

    Lunch
    (On Own)

    1:00 PM- 3:30 PM

    Parallel Sessions:

    Session 1: Clinical Research as Care Option
              Jeremy Sohn, VP, Digital Business Development, Novartis
              Kyu Rhee, Chief Health Officer, IBM Watson
              Steve Rosenberg, SVP & GM, Oracle Health
              John Reites, Chief Product Officer, THREAD
              Drew Schiller, CEO & Co-Founder, Validic
              Marcella Debidda, VP Patient Engagement, Science 37
              Jason Baumgartner, BEK Health
              Reed Tuckson, Managing Director, Tuckson Health Connections

    Session 2: Thunder Pain and Lightning Round
              Howard Hassman, Hassman Research Institute (HRI)
              Larry Ereshefsky, HRI, Follow the Molecule
              Johan den Boer, PRA
              Mike Royal, Liquidia Technologies
              Krista Hill, HRI
              Jay Kranzler

    Session 3: Technology and the Future of Cognition
              Paul Maruff, Chief Science Officer, Cogstate
              Richard Keefe, Co-Founder & CEO, NeuroCog Trials
              Francesca Cormack, Director of Research & Innovation, Cambridge Cognition
              Tom Insel, Co-Founder & President, Mindstrong
              Philip Harvey, Professor of Psychiatry & Behavioral Sciences, University of Miami Miller School of Medicine
              Luca Pani, University of Miami, former CHMP & SAWP Member, European Medicines Agency
              Moderator: William Jacobson

    3:30 PM- 4:30 PM

    Patron and VIP Reception
    -- BY INVITATION ONLY --

    4:30 PM- 5:00 PM

    CNS Summit 2017 New Participant Reception

    5:00 pm- 6:30 pm

    CNS Summit 2017 Welcome Reception
  • + -

    Friday, November 17, 2017

    7:00 AM- 7:45 AM

    Breakfast

    8:00 AM- 12:00 PM

    Welcome Remarks

    Introductory Address
    Amir Kalali
    Chief Curator, CNS Summit

    CNS Summit 2017 Keynote Session
    Adam Gazzaley, Co-Founder, Chief Science Advisor, Akili Interactive Labs
    Eddie Martucci, Co-Founder & CEO, Akili Interactive Labs
    David Bach, Founder & President, Platypus Institute
    Daphne Zohar, Founder & CEO, PureTech Health
    Milind Kamkolkar, Chief Data Officer, Sanofi
    Tom Insel, Co-Founder & President, Mindstrong
    Ron Cohen, President & CEO, Acorda Therapeutics
    Don Jones, Chief Digital Officer, Scripps Translational Science Institute
    Melinda Richter, Global Head, JLABS
    John Nosta, Founder, NostaLabs
    Mike Rea, CEO, IDEA Pharma
    Jane Metcalfe, Founder, WIRED Magazine, Neo.Life
    Nick Adkins, Founder, Pinksocks, Healthcare Evangelist

    CNS Summit 2017 Innovation Index

    12:00 pm- 1:00 pm

    Innovation Showcase
    Michelle Longmire, Co-Founder & CEO, Medable
    Jim Harper, Co-Founder & CEO, Sonde Health
    Leila Pirhaji, Co-Founder & CEO, ReviveMed
    Ardy Arianpour, Co-Founder & CEO, [stealth company]
    Wout Brusselaers, CEO, Deep 6
    Moderated By Spyros Papapetropoulos, Cavion and Georgia Mitsi, Sunovion

    1:00 pm- 1:30 pm

    Solution Showcase
    (Lunch Provided)
    Yonatan Dolan, INTEL

    1:30 pm- 3:30 pm

    CNS Summit Parallel Sessions:


    Session 1: Site of the Future
              David Walling, CEO, Collaborative Neuroscience Network
              Sean Stanton, COO, Global Clinical Research, Bioclinica
              Ellyn Getz, Sr Manager, Development and Community Engagement, CISCRP
              Elan Cohen, Investigator, Hassman Research Group
              Christian Burns, President & Co-founder, ClinEdge & BTC
              Bonnie Segal, Vice President & Co-Founder, Segal Trials

    Session 2: Revolutionizing Outcome Measures in Alzheimer's Trials
              John Harrison, Alzheimer Center, VUmc, Amsterdam
              Maria Carrillo, Chief Science Officer, Alzheimer's Association
              Charles Wilcox, Executive Director, Pharmacology Research Institute
              David Miller, Clinical Vice President, Bracket
              Monika Vance, Founder & Managing Director, Santium
              Suzanne Hendrix, President, Pentara Corporation
              Michael Gold, Vice-President, Development Neurosciences, AbbVie
              Bill Holt, Executive Director, Neuroscience, PRA Health Sciences

    Session 3: Digital Biomarkers: How to Implement
              Barry Bedell, COO & CSO, Biospective
              Deborah Kilpatrick, CEO, Evidation
              Bakul Patel, Digital Health, U.S. Food & Drug Administration (FDA)
              Larsson Omberg, VP Systems Biology, SAGE Bionetworks
              Adam Hanina, CEO, AiCure
              Eddie Martucci, CEO, Akili Interactive Labs
              Moderator: Brad Miller, Sr. Managing Director, Lilly

    Session 4: Remote Research Workshop
              John Reites, Chief Product Officer, THREAD

    Session 5: Neuroscience Session
              Harry Tracy, Founder & President, NI Research
              Ali Rezai, Founder & Chief of Science, Neurotechnology Innovations Translator (NIT)
              Kenneth Koblan, Head,Global Translational Medicine & Early Development - TMED, Sunovion
              Margaretta Nyilas, SVP, Clinical Management & Business Operations, Otsuka

    3:30 pm- 5:00 pm

    One-to-One Networking Sessions

    5:00 pm- 7:00 pm

    Evening Reception, Posters & Exhibits
  • + -

    Saturday, November 18, 2017

    7:00 AM- 7:45 AM

    Breakfast

    8:00 AM - 12:00 PM

    Welcome Remarks

    CNS Summit 2017 Keynote Session
    Bakul Patel, Head, Digital Health, FDA
    Corey McCann, CEO, Pear Therapeutics
    Joseph Owens, X, (Google)
    Elliot Menschik, Life Sciences, Amazon
    Larsson Omberg, SAGE Bionetworks
    Mikkel Hansen, Chief Medical Officer, Philips
    Jennifer Goldsack, CTTI
    Glen de Vries, President, Medidata
    Cynthia Verst, President, QuintilesIMS
    Nuala Murphy, President, ICON
    Alistar Macdondald, CEO, INC Research
    Brent Saunders, CEO, Allergan
    David Nicholson, Chief R&D Officer, Allergan
    Armin Szegedi, VP Clinical Development, Allergan

    12:00 pm- 1:00 pm

    Innovation Showcase
    Michael Hufford, CEO, LyGenesis
    Mario Weiss, CEO, GAIA AG
    Niousha Bolandzadeh, Founder & CEO, Brite Health
    Joseph Geraci, Founder, NetraMark
    Moderated By Spyros Papapetropoulos, Cavion and Georgia Mitsi, Sunovion

    1:00 pm- 1:30 pm

    Solution Showcase
    (Lunch Provided)
    Al O. Pacino, President, BlueCloud® by HealthCarePoint

    1:30 pm- 3:30 pm

    CNS Summit Parallel Sessions:


    Session 1: Drug Development Nirvana:
    Site Operations Impact on Life Sciences

              Tim Peters-Strickland, Senior Director, Global Clinical Development, Otsuka
              Joris Van Dam, Strategic Projects Manager, Novartis
              Lori Wright, CEO, Evolution Research Group
              Sean Walsh, Chief Development Officer, Raleigh Neurology Associates
              Rishi Kakar, CSO, Segal Trials
              David Daniel, SVP & CMO, Bracket
              Christian Burns, President, ClinEdge
              Moderated by Lisa LaLuna, SVP, ePharmaSolutions

    Session 2: Optimizing Mobile Technology for Data Capture in Clinical Trials
              Sohini Chowdhury, Deputy CEO, Michael J. Fox Foundation
              Jennifer Goldsack, Clinical Trials Transformation Initiative (CTTI)
              Barry Peterson, Scientific Consultant, Philips Healthcare
              John Reites, Chief Product Officer, THREAD
              Kaveeta Vasisht, U.S. Food & Drug Administration (FDA)
              Moderator: Jessie Bakker, Sr. Manager, Clinical Affairs, Philips Healthcare

    Session 3: Design Thinking
              Bill Evans, Founder, Bridge Design, Ximedica
              Andrew Chacko, Principal, ChackoMD

    Session 4: Transforming Healthcare: How AI and Machine Learning are Powering Better Patient Care from Drug Discovery to the Doctor’s Office
              Joel Dudley, Director of Institute for Next Generation Healthcare, Icahn School of Medicine, Mount Sinai
              Tom Vogt, VP Discovery & Systems Biology, CHDI Foundation (Huntington’s Disease)
              Lonny Northrup, Sr. Health Informaticist, Intermountain Healthcare
              Erik Peraklis, SVP, Informatics, Takeda Pharmaceuticals
              Moderator: Diane Wuest, Precision Medicine Lead, GNS Healthcare

    Session 5: Neuroscience Session
              Dimitri Gridoriadis, Chief Research Officer, Neurocrine
              Ajay Verma, Chief Medical Officer, United Neuroscience
              Roger Bullock, Chief Medical Officer, Oryzon Genomics
              Sharon Mates, CEO, Intra-Cellular Therapies
              Cedric O’Gorman, SVP, Clinical Development & Medical Affairs, Axsome Therapeutics

    3:30 pm- 5:00 pm

    One-to-One Networking Sessions

    5:00 pm- 7:00 pm

    Evening Reception, Posters & Exhibits
  • + -

    Sunday, November 19, 2017

    7:30 am- 8:15 am

    Breakfast

    8:30 am- 12:00 pm

    Welcome Remarks

    CNS Summit 2017 Keynote Session

    The Patient Advocacy and Patient Engagement Networks (PENS) Role in the Life Sciences Industry
    Sohini Chowdhury, Deputy CEO, Michael J. Fox Foundation
    Chris Snyder, Director, American Cancer Society
    Susan Manoff, Executive Director, Office of the Chief Patient Officer, Merck
    Patricia Roselle, Associate Director, Patient Networks, Sanofi
    T. J. Sharpe, Patient Advocate
    Ken Getz, Founder and Chairman; CISCRP
    Jennifer Byrne, Founder, Greater Gift

    12:00 pm

    Adjourn